Allergy and Lung Health Unit, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Department of Toxicology, Hanoi University of Pharmacy, Hanoi, Vietnam.
Allergy and Lung Health Unit, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Lancet Respir Med. 2018 Jul;6(7):535-544. doi: 10.1016/S2213-2600(18)30100-0. Epub 2018 Apr 5.
Lifetime lung function is related to quality of life and longevity. Over the lifespan, individuals follow different lung function trajectories. Identification of these trajectories, their determinants, and outcomes is important, but no study has done this beyond the fourth decade.
We used six waves of the Tasmanian Longitudinal Health Study (TAHS) to model lung function trajectories measured at 7, 13, 18, 45, 50, and 53 years. We analysed pre-bronchodilator FEV z-scores at the six timepoints using group-based trajectory modelling to identify distinct subgroups of individuals whose measurements followed a similar pattern over time. We related the trajectories identified to childhood factors and risk of chronic obstructive pulmonary disease (COPD) using logistic regression, and estimated population-attributable fractions of COPD.
Of the 8583 participants in the original cohort, 2438 had at least two waves of lung function data at age 7 years and 53 years and comprised the study population. We identified six trajectories: early below average, accelerated decline (97 [4%] participants); persistently low (136 [6%] participants); early low, accelerated growth, normal decline (196 [8%] participants); persistently high (293 [12%] participants); below average (772 [32%] participants); and average (944 [39%] participants). The three trajectories early below average, accelerated decline; persistently low; and below average had increased risk of COPD at age 53 years compared with the average group (early below average, accelerated decline: odds ratio 35·0, 95% CI 19·5-64·0; persistently low: 9·5, 4·5-20·6; and below average: 3·7, 1·9-6·9). Early-life predictors of the three trajectories included childhood asthma, bronchitis, pneumonia, allergic rhinitis, eczema, parental asthma, and maternal smoking. Personal smoking and active adult asthma increased the impact of maternal smoking and childhood asthma, respectively, on the early below average, accelerated decline trajectory.
We identified six potential FEV trajectories, two of which were novel. Three trajectories contributed 75% of COPD burden and were associated with modifiable early-life exposures whose impact was aggravated by adult factors. We postulate that reducing maternal smoking, encouraging immunisation, and avoiding personal smoking, especially in those with smoking parents or low childhood lung function, might minimise COPD risk. Clinicians and patients with asthma should be made aware of the potential long-term implications of non-optimal asthma control for lung function trajectory throughout life, and the role and benefit of optimal asthma control on improving lung function should be investigated in future intervention trials.
National Health and Medical Research Council of Australia; European Union's Horizon 2020; The University of Melbourne; Clifford Craig Medical Research Trust of Tasmania; The Victorian, Queensland & Tasmanian Asthma Foundations; The Royal Hobart Hospital; Helen MacPherson Smith Trust; and GlaxoSmithKline.
终生肺功能与生活质量和寿命有关。在整个生命周期中,个体遵循不同的肺功能轨迹。确定这些轨迹、它们的决定因素和结果很重要,但在第四十年后,没有研究做到这一点。
我们使用塔斯马尼亚纵向健康研究(TAHS)的六波数据来模拟在 7、13、18、45、50 和 53 岁时测量的肺功能轨迹。我们使用基于群组的轨迹建模来分析六个时间点的预支气管扩张剂 FEV z 分数,以确定在随时间推移的相似模式下跟随的个体的不同亚组。我们使用逻辑回归将识别出的轨迹与儿童时期的因素和慢性阻塞性肺疾病(COPD)的风险联系起来,并估计 COPD 的人群归因分数。
在最初的队列中,8583 名参与者中有 2438 名至少有两次在 7 岁和 53 岁时的肺功能数据,构成了研究人群。我们确定了六个轨迹:早期低于平均水平,加速下降(97[4%]参与者);持续低水平(136[6%]参与者);早期低水平,加速增长,正常下降(196[8%]参与者);持续高水平(293[12%]参与者);低于平均水平(772[32%]参与者);和平均水平(944[39%]参与者)。与平均组相比,三个轨迹(早期低于平均水平、加速下降;持续低水平;和低于平均水平)在 53 岁时患有 COPD 的风险增加(早期低于平均水平、加速下降:比值比 35.0,95%CI 19.5-64.0;持续低水平:9.5,4.5-20.6;和低于平均水平:3.7,1.9-6.9)。三个轨迹的早期生命预测因素包括儿童时期的哮喘、支气管炎、肺炎、过敏性鼻炎、湿疹、父母的哮喘和母亲吸烟。个人吸烟和成人期哮喘会增加母亲吸烟和儿童期哮喘对早期低于平均水平、加速下降轨迹的影响。
我们确定了六个潜在的 FEV 轨迹,其中两个是新的。三个轨迹占 COPD 负担的 75%,与可改变的生命早期暴露有关,这些暴露的影响因成人因素而加剧。我们假设减少母亲吸烟、鼓励免疫接种以及避免个人吸烟,特别是在那些有吸烟父母或儿童期肺功能较低的人,可能会降低 COPD 的风险。临床医生和哮喘患者应该意识到非最佳哮喘控制对终生肺功能轨迹的潜在长期影响,并且应该在未来的干预试验中研究最佳哮喘控制对改善肺功能的作用和益处。
澳大利亚国家卫生和医学研究委员会;欧盟地平线 2020 计划;墨尔本大学;塔斯马尼亚州克利福德·克雷格医学研究信托基金;维多利亚州、昆士兰州和塔斯马尼亚州哮喘基金会;皇家霍巴特医院;海伦·麦克弗森·史密斯信托基金;和葛兰素史克公司。